Obestatin: Is it really doing something?

How Gut and Brain Control Metabolism

Volumn 42, Issue , 2014, Pages 175-185

  Trovato, Letizia ^a   Gallo, Davide ^a   Settanni, Fabio ^a   Gesmundo, Iacopo ^a   Ghigo, Ezio ^a   Granata, Riccarda ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925848422     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000358346     Document Type: Chapter

References (57)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Mohan H, Unniappan S: Discovery of ghrelin O-acyltransferase. Endocr Dev 2013; 25: 16-24.
3. Delhanty PJ, Neggers SJ, van der Lely AJ: Des-acyl ghrelin: a metabolically active peptide. Endocr Dev 2013; 25: 112-121.
4. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
5. Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E: Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010; 45: 107-118.
6. Zhang JV, Jahr H, Luo CW, Klein C, Van Kolen K, Ver Donck L, De A, Baart E, Li J, Moechars D, Hsueh AJ: Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G-protein-coupled receptor, GPR39. Mol Endocrinol 2008; 22: 1464-1475.
7. Zhang JV, Li L, Huang Q, Ren PG: Obestatin receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci 2013; 114: 89-107.
8. Ren G, He Z, Cong P, Chen H, Guo Y, Yu J, Liu Z, Ji Q, Song Z, Chen Y: Peripheral administration of TAT-obestatin can influence the expression of liporegulatory genes but fails to affect food intake in mice. Peptides 2013; 42C:8-14.
9. Granata R, Gallo D, Luque RM, Baragli A, Scarlatti F, Grande C, Gesmundo I, Cordoba-Chacon J, Bergandi L, Settanni F, Togliatto G, Volante M, Garetto S, Annunziata M, Chanclon B, Gargantini E, Rocchietto S, Matera L, Datta G, Morino M, Brizzi MF, Ong H, Camussi G, Castano JP, Papotti M, Ghigo E: Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 2012; 26: 3393-3411.
10. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghè C, Volante M, Papotti M, Muccioli G, Ghigo E: Obestatin promotes survival of pancreatic β-cells and human islets and induces expression of genes involved in the regulation of β-cell mass and function. Diabetes 2008; 57: 967-979.
11. Alloatti G, Arnoletti E, Bassino E, Penna C, Perrelli MG, Ghè C, Muccioli G: Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol 2010; 299:H470-H481.
12. Dun SL, Brailoiu GC, Brailoiu E, Yang J, Chang JK, Dun NJ: Distribution and biological activity of obestatin in the rat. J Endocrinol 2006; 191: 481-489.
13. Chanoine JP, Wong AC, Barrios V: Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 2006; 66: 81-88.
14. Bang AS, Soule SG, Yandle TG, Richards AM, Pemberton CJ: Characterisation of proghrelin peptides in mammalian tissue and plasma. J Endocrinol 2007; 192: 313-323.
15. Gronberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J: Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 2008; 56: 793-801.
16. Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R, Papotti M: Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 2009; 218: 458-466.
17. Zhao CM, Furnes MW, Stenstrom B, Kulseng B, Chen D: Characterization of obestatin-and ghrelinproducing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575-587.
18. Gurriaran-Rodriguez U, Santos-Zas I, Al-Massadi O, Mosteiro CS, Beiroa D, Nogueiras R, Crujeiras AB, Seoane LM, Senaris J, Garcia-Caballero T, Gallego R, Casanueva FF, Pazos Y, Camina JP: The obestatin/GPR39 system is upregulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem 2012; 287: 38379-38389.
19. Moretti E, Vindigni C, Tripodi SA, Mazzi L, Nuti R, Figura N, Collodel G: Immunolocalisation of ghrelin and obestatin in human testis, seminal vesicles, prostate and spermatozoa. Andrologia 2013, Epub ahead of print.
20. Seim I, Walpole C, Amorim L, Josh P, Herington A, Chopin L: The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease. Mol Cell Endocrinol 2012; 340: 111.
21. Huda MS, Mani H, Durham BH, Dovey TM, Halford JC, Aditya BS, Pinkney JH, Wilding JP, Hart IK: Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged. Endocrine 2013; 43: 696-704.
22. Cui AD, Gai NN, Zhang XH, Jia KZ, Yang YL, Song ZJ: Decreased serum obestatin consequent upon TRIB3 Q84R polymorphism exacerbates carotid atherosclerosis in subjects with metabolic syndrome. Diabetol Metab Syndr 2012; 4: 52.
23. Gronberg M, Tsolakis AV, Holmback U, Stridsberg M, Grimelius L, Janson ET: Ghrelin and obestatin in human neuroendocrine tumors: expression and effect on obestatin levels after food intake. Neuroendocrinology 2013; 97: 291-299.
24. Alexandridis E, Zisimopoulos A, Liratzopoulos N, Katsos I, Manolas K, Kouklakis G, Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 1557-1561.
25. Gao XY, Kuang HY, Liu XM, Ma ZB, Nie HJ, Guo H: Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 2008; 29: 1749-1754.
26. Ulasoglu C, Isbilen B, Doganay L, Ozen F, Kiziltas S, Tuncer I: Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels. World J Gastroenterol 2013; 19: 2388-2394.
27. Green BD, Irwin N, Flatt PR: Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007; 28: 981-987.
28. Samson WK, White MM, Price C, Ferguson AV: Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 2007; 292:R637-R643.
29. Carlini VP, Schioth HB, Debarioglio SR: Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 2007; 352: 907-912.
30. Szentirmai E, Krueger JM: Obestatin alters sleep in rats. Neurosci Lett 2006; 404: 222-226.
31. Camina JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF: Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol 2007; 211: 1-9.
32. Pazos Y, Alvarez CJ, Camina JP, Casanueva FF: Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 2007; 25: 373-381.
33. Granata R, Volante M, Settanni F, Gauna C, Ghè C, Annunziata M, Deidda B, Gesmundo I, Abribat T, van der Lely AJ, Muccioli G, Ghigo E, Papotti M: Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocintreated newborn rats. J Mol Endocrinol 2010; 45: 9-17.
34. Favaro E, Granata R, Miceli I, Baragli A, Settanni F, Cavallo Perin P, Ghigo E, Camussi G, Zanone MM, The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 2012; 55: 1058-1070.
35. Baragli A, Grande C, Gesmundo I, Settanni F, Taliano M, Gallo D, Gargantini E, Ghigo E, Granata R: Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS One 2013; 8:e64374.
36. Gurriaran-Rodriguez U, Al-Massadi O, Roca-Rivada A, Crujeiras AB, Gallego R, Pardo M, Seoane LM, Pazos Y, Casanueva FF, Camina JP: Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 2011; 15: 1927-1940.
37. Miegueu P, St Pierre D, Broglio F, Cianflone K: Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 2011; 112: 704-714.
38. Pruszynska-Oszmalek E, Szczepankiewicz D, Hertig I, Skrzypski M, Sassek M, Kaczmarek P, Kolodziejski PA, Mackowiak P, Nowak KW, Strowski MZ, Wojciechowicz T: Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J Biol Regul Homeost Agents 2013; 27: 23-33.
39. Aragno M, Mastrocola R, Ghè C, Arnoletti E, Bassino E, Alloatti G, Muccioli G: Obestatin-induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol 2012; 11: 129.
40. Kellokoski E, Kunnari A, Jokela M, Makela S, Kesaniemi YA, Horkko S: Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 2009; 58: 1572-1580.
41. Ceranowicz P, Warzecha Z, Dembinski A, Cieszkowski J, Dembinski M, Sendur R, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I: Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J Physiol Pharmacol 2009; 60: 95-101.
42. Agnew A, Calderwood D, Chevallier OP, Greer B, Grieve DJ, Green BD: Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats. Peptides 2011; 32: 755-762.
43. Grala TM, Kay JK, Walker CG, Sheahan AJ, Littlejohn MD, Lucy MC, Roche JR, Expression analysis of key somatotropic axis and liporegulatory genes in ghrelin-and obestatin-infused dairy cows. Domest Anim Endocrinol 2010; 39: 76-83.
44. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR, Olefsky JM: SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29: 1363-1374.
45. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
46. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA: Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100: 2858-2864.
47. Walia P, Asadi A, Kieffer TJ, Johnson JD, Chanoine JP: Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res 2009; 65: 39-44.
48. Turk N, Dagistanli FK, Sacan O, Yanardag R, Bolkent S: Obestatin and insulin in pancreas of newborn diabetic rats treated with exogenous ghrelin. Acta Histochem 2012; 114: 349-357.
49. Donath MY, Halban PA: Decreased β-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004; 47: 581-589.
50. Wierup N, Svensson H, Mulder H, Sundler F: The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
51. Qader SS, Hakanson R, Rehfeld JF, Lundquist I, Salehi A: Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 2008; 146: 230-237.
52. Ren AJ, Guo ZF, Wang YK, Wang LG, Wang WZ, Lin L, Zheng X, Yuan WJ: Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 2008; 369: 969-972.
53. Egido EM, Hernandez R, Marco J, Silvestre RA: Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2009.
54. Anderwald-Stadler M, Krebs M, Promintzer M, Mandl M, Bischof MG, Nowotny P, Kastenbauer T, Luger A, Prager R, Anderwald C: Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 2007; 293:E1393-E1398.
55. Li ZF, Guo ZF, Cao J, Hu JQ, Zhao XX, Xu RL, Huang XM, Qin YW, Zheng X: Plasma ghrelin and obestatin levels are increased in spontaneously hypertensive rats. Peptides 2010; 31: 297-300.
56. Ren AJ, He Q, Shi JS, Guo ZF, Zheng X, Lin L, Wang YK, Xia SY, Sun LL, Du X, Sun Y, Zhang LM, Yuan WJ: Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides 2009; 30: 1742-1745.
57. Iglesias MJ, Salgado A, Pineiro R, Rodino BK, Otero MF, Grigorian L, Gallego R, Dieguez C, Gualillo O, Gonzalez-Juanatey JR, Lago F: Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J Endocrinol Invest 2007; 30: 470-476.